TBLR1 is a novel prognostic marker and promotes epithelial-mesenchymal transition in cervical cancer

British Journal of Cancer

Volumn 111, Issue 1, 2014, Pages 112-124

  Wang, J ^a,b   Ou, J ^a   Guo, Y ^a   Dai, T ^b   Li, X ^b   Liu, J ^a   Xia, M ^a   Liu, L ^a   He, M ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

cervical cancer; epithelial mesenchymal transition; pelvic lymph node metastasis; TBLR1

Indexed keywords

ALPHA CATENIN; BETA CATENIN; FIBRONECTIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIGEL; MESSENGER RNA; RNA; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR TWIST; TRANSDUCIN BETA LIKE PROTEIN 1 RELATED PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG; VIMENTIN; WNT PROTEIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER TISSUE; CELL INVASION ASSAY; CELL MOTILITY; CERVICAL CANCER CELL LINE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; HELA CELL LINE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUCIFERASE ASSAY; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SURVIVAL TIME; TUMOR INVASION; TUMOR MODEL; TUMOR XENOGRAFT; UPREGULATION; UTERINE CERVIX CANCER; WESTERN BLOTTING; WOUND HEALING;

ADULT; AGED; ANIMALS; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HELA CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHATIC METASTASIS; MICE; MICE, INBRED BALB C; MICE, NUDE; MIDDLE AGED; NUCLEAR PROTEINS; PROGNOSIS; RECEPTORS, CYTOPLASMIC AND NUCLEAR; REPRESSOR PROTEINS; RETROSPECTIVE STUDIES; RNA, SMALL INTERFERING; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; XENOGRAFT MODEL ANTITUMOR ASSAYS; YOUNG ADULT;

EID: 84904103630     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2014.278     Document Type: Article

References (50)

1. Altgassen C, Hertel H, Brandsta?dt A, Kohler C, Du?rst M, Schneider A (2008) Multicenter validation study of the sentinel lymph node concept in cervical cancer: AGO Study Group. J Clin Oncol 26: 2943-2951.
2. An Q, Pacyna-Gengelbach M, Schlu?ns K, Deutschmann N, Guo S, Gao Y, Zhang J, Cheng S, Petersen I (2003) Identification of differentially expressed genes in immortalized human bronchial epithelial cell line as a model for in vitro study of lung carcinogenesis. Int J Cancer 103: 194-204.
3. Andersson S, Wallin KL, Hellstrom AC, Morrison LE, Hjerpe A, Auer G, Ried T, Larsson C, Heselmeyer-Haddad K (2006) Frequent gain of the human telomerase gene TERC at 3q26 in cervical adenocarcinomas. Br J Cancer 95: 331-338.
4. Barberà MJ, Puig I, Domnguez D, Julien-Grille S, Guaita-Esteruelas S, Peiro? S, Baulida J, Franc C, Dedhar S, Larue L (2004) Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells. Oncogene 23: 7345-7354.
5. Baritaki S, Huerta-Yepez S, Sahakyan A, Karagiannides I, Bakirtzi K, Jazirehi A, Bonavida B (2010) Mechanisms of nitric oxide-mediated inhibition of EMT in cancer: Inhibition of the metastasis-inducer Snail and induction of the metastasis-suppressor RKIP. Cell Cycle 9: 4931-4940.
6. Benedet JL, Bender H, Jones HR, Ngan HY, Pecorelli S (2000) FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology. Int J Gynaecol Obstet 70: 209-262.
7. Biewenga P, van der Velden J, Mol BW, Stalpers LJ, Schilthuis MS, van der Steeg JW, Burger MP, Buist MR (2011) Prognostic model for survival in patients with early stage cervical cancer. Cancer 117: 768-776.
8. Cabannes E, Khan G, Aillet F, Jarrett RF, Hay RT (1999) Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkBa. Oncogene 18: 3063-3070.
9. Chen Y, Zhang L, Tian J, Fu X, Ren X, Hao Q (2013) Significance of the absolute number and ratio of metastatic lymph nodes in predicting postoperative survival for the International Federation of Gynecology and Obstetrics stage IA2 to IIA cervical cancer. Int J Gynecol Cancer 23: 157-163.
10. Choi HK, Choi KC, Yoo JY, Song M, Ko SJ, Kim CH, Ahn JH, Chun KH, Yook JI, Yoon HG (2011) Reversible SUMOylation of TBL1-TBLR1 regulates beta-catenin-mediated Wnt signaling. Mol Cell 43: 203-216.
11. Chung MT, Lai HC, Sytwu HK, Yan MD, Shih YL, Chang CC, Yu MH, Liu HS, Chu DW, Lin YW (2009) SFRP1 and SFRP2 suppress the transformation and invasion abilities of cervical cancer cells through Wnt signal pathway. Gynecol Oncol 112: 646-653.
12. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin H (2010) Human papillomavirus genotype attribution in invasive cervical cancer: A retrospective cross-sectional worldwide study. Lancet Oncol 11: 1048-1056.
13. Garg M, Kanojia D, Saini S, Suri S, Gupta A, Surolia A, Suri A (2010) Germ cell-specific heat shock protein 70-2 is expressed in cervical carcinoma and is involved in the growth, migration, and invasion of cervical cells. Cancer 116: 3785-3796.
14. Grandori C, Cowley SM, James LP, Eisenman RN (2000) The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Bi 16: 653-699.
15. Hoberg JE, Yeung F, Mayo MW (2004) SMRT derepression by the IkappaB kinase alpha: A prerequisite to NF-kappaB transcription and survival. Mol Cell 16: 245-255.
16. Hsu YM, Chen YF, Chou CY, Tang MJ, Chen JH, Wilkins RJ, Ellory JC, Shen MR (2007) KCl cotransporter-3 down-regulates E-cadherin/betacatenin complex to promote epithelial-mesenchymal transition. Cancer Res 67: 11064-11073.
17. Huang A, Hsu S, Kuo C, Liao C, Lai K, Lin T, Wu S, Lu H, Tang N, Yang J (2009) Involvement of Matrix Metalloproteinases in the Inhibition of Cell Invasion and Migration Through the Inhibition of NF-kB by the New Synthesized Ethyl 2-[Np-chlorobenzyl-(20-methyl)] anilino-4-oxo-4, 5-dihydrofuran-3- carboxylate (JOTO1007) in Human Cervical Cancer CaSki Cells. In Vivo 23: 613-619.
18. Ishii S, Kurasawa Y, Wong J, Yu-Lee LY (2008) Histone deacetylase 3 localizes to the mitotic spindle and is required for kinetochore-microtubule attachment. Proc Natl Acad Sci USA 105: 4179-4184.
19. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
20. Julien S, Puig I, Caretti E, Bonaventure J, Nelles L, van Roy F, Dargemont C, de Herreros AG, Bellacosa A, Larue L (2007) Activation of NF-kappaB by Akt upregulates Snail expression and induces epithelium mesenchyme transition. Oncogene 26: 7445-7756.
21. Kodama J, Seki N, Masahiro S, Kusumoto T, Nakamura K, Hongo A, Hiramatsu Y (2010) Prognostic factors in stage IB-IIB cervical adenocarcinoma patients treated with radical hysterectomy and pelvic lymphadenectomy. J Surg Oncol 101: 413-417.
22. Kumar V, Behera R, Lohite K, Karnik S, Kundu GC (2010) p38 kinase is crucial for osteopontin-induced furin expression that supports cervical cancer progression. Cancer Res 70: 10381-10391.
23. Laudadio J (2013) Human papillomavirus detection: Testing methodologies and their clinical utility in cervical cancer screening. Adv Anat Pathol 20: 158-167.
24. Lee MY, Chou CY, Tang MJ, Shen MR (2008) Epithelial-mesenchymal transition in cervical cancer: Correlation with tumor progression, epidermal growth factor receptor overexpression, and snail up-regulation. Clin Cancer Res 14: 4743-4750.
25. Li J, Jia H, Xie L, Wang X, Wang X, He H, Lin Y, Hu L (2009) Association of constitutive nuclear factor-kappaB activation with aggressive aspects and poor prognosis in cervical cancer. Int J Gynecol Cancer 19: 1421-1426.
26. Li J, Wang C (2008) TBL1-TBLR1 and beta-catenin recruit each other to Wnt target-gene promoter for transcription activation and oncogenesis. Nat Cell Biol 10: 160-169.
27. Li Y, Wang W, Wang W, Yang R, Wang T, Su T, Weng D, Tao T, Li W, Ma D, Wang S (2012) Correlation of TWIST2 up-regulation and epithelialmesenchymal transition during tumorigenesis and progression of cervical carcinoma. Gynecol Oncol 124: 112-118.
28. Mayrand MH, Duarte-Franco E, Rodrigues I, Walter SD, Hanley J, Ferenczy A, Ratnam S, Coutle?e F, Franco EL (2007) Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer. N Engl J Med 357: 1579-1588.
29. Min C, Eddy SF, Sherr DH, Sonenshein GE (2008) NF-kappaB and epithelial to mesenchymal transition of cancer. J Cell Biochem 104: 733-744.
30. Mun?oz N, Bosch FX, de Sanjose? S, Herrero R, Castellsague? X, Shah KV, Snijders PJ, Meijer CJ (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl J Med 348: 518-527.
31. Noordhuis MG, Fehrmann RS, Wisman GB, Nijhuis ER, van Zanden JJ, Moerland PD, LVTE Ver, Volders HH, Kok M, Ten HK, Hollema H, de Vries EG, de Bock GH, van der Zee AG, Schuuring E (2011) Involvement of the TGF-beta and beta-catenin pathways in pelvic lymph node metastasis in early-stage cervical cancer. Clin Cancer Res 17: 1317-1330.
32. Perissi V, Aggarwal A, Glass CK, Rose DW, Rosenfeld MG (2004) A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors. Cell 116: 511-526.
33. Perissi V, Scafoglio C, Zhang J, Ohgi KA, Rose DW, Glass CK, Rosenfeld MG (2008) TBL1 and TBLR1 phosphorylation on regulated gene promoters overcomes dual CtBP and NCoR/SMRT transcriptional repression checkpoints. Mol Cell 29: 755-766.
34. Polyak K, Weinberg RA (2009) Transitions between epithelial and mesenchymal states: Acquisition of malignant and stem cell traits. Nat Rev Cancer 9: 265-273.
35. Powell ML, Smith JA, Sowa ME, Harper JW, Iftner T, Stubenrauch F, Howley PM (2010) NCoR1 mediates papillomavirus E8E2C transcriptional repression. J Virol 84: 4451-4460.
36. Ravindranath A, Yuen HF, Chan KK, Grills C, Fennell DA, Lappin TR, El-Tanani M (2011) Wnt-b-Catenin-Tcf-4 signalling-modulated invasiveness is dependent on osteopontin expression in breast cancer. Brit J Cancer 105: 542-551.
37. Selman TJ, Mann C, Zamora J, Appleyard TL, Khan K (2008) Diagnostic accuracy of tests for lymph node status in primary cervical cancer: A systematic review and meta-analysis. CMAJ 178: 855-862.
38. Shagieva GS, Domnina LV, Chipysheva TA, Ermilova VD, Chaponnier C, Dugina VB (2012) Actin isoforms and reorganization of adhesion junctions in epithelial-to-mesenchymal transition of cervical carcinoma cells. Biochemistry (Mosc) 77: 1266-1276.
39. Shibata K, Kajiyama H, Ino K, Terauchi M, Yamamoto E, Nawa A, Nomura S, Kikkawa F (2008) Twist expression in patients with cervical cancer is associated with poor disease outcome. Ann Oncol 19: 81-85.
40. Siegel R, Ward E, Brawley O, Jemal A (2011) Cancer statistics, 2011. CA Cancer J Clin 61: 212-236.
41. Slama J, Dundr P, Dusek L, Cibula D (2013) High false negative rate of frozen section examination of sentinel lymph nodes in patients with cervical cancer. Gynecol Oncol 129: 384-388.
42. Song L, Gong H, Lin C, Wang C, Liu L, Wu J, Li M, Li J (2012) Flotillin-1 promotes tumor necrosis factor-a receptor signaling and activation of NF-kB in esophageal squamous cell carcinoma cells. Gastroenterology 143: 995-1005.
43. Song LB, Li J, Liao WT, Feng Y, Yu CP, Hu LJ, Kong QL, Xu LH, Zhang X, Liu WL, Li MZ, Zhang L, Tsao SW, Li M, Band V, Band H, Shi QH, Zeng YX, Zeng MS (2009) The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest 119: 3626-3636.
44. Wangsa D, Heselmeyer-Haddad K, Ried P, Eriksson E, Scha?ffer AA, Morrison LE, Luo J, Auer G, Munck-Wikland E, Ried T, Lundqvist E? (2009) Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases. Am J Pathol 175: 2637-2645.
45. Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham D, Glennie MJ, Kelland LR, Robinson V, Stratford IJ, Tozer GM, Watson S, Wedge SR, Eccles SA. An ad hoc committee of the National Cancer Research Institute (2010) Guidelines for the welfare and use of animals in cancer research. Br J Cancer 102: 1555-1577.
46. Wu Z, Peng X, Li J, Zhang Y, Hu L (2013) Constitutive activation of nuclear factor kappaB contributes to cystic fibrosis transmembrane conductance regulator expression and promotes human cervical cancer progression and poor prognosis. Int J Gynecol Cancer 23: 906-915.
47. Yang YC, Shyong WY, Chang MS, Chen YJ, Lin CH, Huang ZD, Wang, Hsu MT, Chen ML (2001) Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma. Cancer Genet Cytogenet 131: 48-53.
48. Yoon HG, Choi Y, Cole PA, Wong J (2005) Reading and function of a histone code involved in targeting corepressor complexes for repression. Mol Cell Biol 25(1): 324-335.
49. Zhang J, Huang K, Shi Z, Zou J, Wang Y, Jia Z, Zhang A, Han L, Yue X, Liu N (2011) High b-catenin/Tcf-4 activity confers glioma progression via direct regulation of AKT2 gene expression. Neuro Oncol 13: 600-609.
50. Zhang J, Kalkum M, Chait BT, Roeder RG (2002) The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol Cell 9: 611-662.